Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatments and Treatment Predictors in Patients With Substance Use Disorders and Comorbid Attention-Deficit/Hyperactivity Disorder: First Results From the International Naturalistic Cohort Study of ADHD and SUD (INCAS).
Brynte C, Schellekens A, Barta C, Begeman AHA, Crunelle CL, Daigre C, Demetrovics Z, Dom G, Grau-López L, Hernandez M, Icick R, Johnson B, Kapitány-Fövény M, van Kernebeek M, Konstenius M, Levin FR, Luderer M, Matthys F, Moggi F, Ramos-Quiroga JA, Schleussner L, Therribout N, Thomas A, Vorspan F, van den Brink W, Franck J. Brynte C, et al. Among authors: begeman aha. J Clin Psychiatry. 2024 Dec 23;86(1):24m15494. doi: 10.4088/JCP.24m15494. J Clin Psychiatry. 2024. PMID: 39724095
[Adolescents with concurrent ADHD and substance use disorder; international consensus].
Spijkerman R, Crunelle CL, Özgen MH, Begeman AHA, Dom G, van de Glind G, Groenman AP, van Kernebeek MW, Matthys F, Post M, Schellekens A, Staal W, van den Brink W, Hendriks VM. Spijkerman R, et al. Among authors: begeman aha. Tijdschr Psychiatr. 2021;63(12):868-874. Tijdschr Psychiatr. 2021. PMID: 34978058 Free article. Dutch.
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.
Brynte C, Aeschlimann M, Barta C, Begeman AHA, Bäcker A, Crunelle CL, Daigre C, De Fuentes-Merillas L, Demetrovics Z, Dom G, López LG, Icick R, Johnson B, Joostens P, Kapitány-Fövény M, Karsinti E, Kiefer F, Konstenius M, Levin FR, Luderer M, Markus W, Matthys F, Moggi F, Palma-Alvarez RF, Paraskevopoulou M, Ramos-Quiroga JA, Schellekens A, Soravia LM, Therribout N, Thomas A, van de Glind G, van Kernebeek MW, Vollstädt-Klein S, Vorspan F, van den Brink W, Franck J. Brynte C, et al. Among authors: begeman aha. BMC Psychiatry. 2022 Sep 23;22(1):625. doi: 10.1186/s12888-022-04259-6. BMC Psychiatry. 2022. PMID: 36151539 Free PMC article.